Parkside Financial Bank & Trust’s Takeda Pharmaceutical TAK Stock Holding History

Parkside Financial Bank & Trust’s Portfolio TAK Stock Details TAK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$47.4K	Hold	2,560	–	–	﹤0.01%	975
2025 Q4	$39.9K	Buy	2,560 +1,684	+192%	+$24.1K	﹤0.01%	1049
2025 Q3	$12.8K	Sell	876 -471	-35%	-$7K	﹤0.01%	1424
2025 Q2	$20.8K	Buy	1,347 +809	+150%	+$12K	﹤0.01%	1219
2025 Q1	$8K	Buy	538 +270	+101%	+$3.78K	﹤0.01%	1486
2024 Q4	$3.55K	Hold	268	–	–	﹤0.01%	1519
2024 Q3	$3.81K	Buy	268 +266	+13,300%	+$3.77K	﹤0.01%	1484
2024 Q2	$26	Sell	2 -58	-97%	-$768	﹤0.01%	2035
2024 Q1	$834	Sell	60 -148	-71%	-$2.15K	﹤0.01%	1653
2023 Q4	$2.97K	Buy	+208	New	+$2.95K	﹤0.01%	1427

Other funds holding TAK

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

BIP

Brandes Investment Partners La Jolla, California $14.1B AUM 25.52% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Parkside Financial Bank & Trust's TAK Position: Q1 2026 in Review

Parkside Financial Bank & Trust held its Takeda Pharmaceutical (TAK) position steady in Q1 2026 at 2,560 shares worth $47.4K. The position accounts for ﹤0.01% of the portfolio, ranked #975.

Parkside Financial Bank & Trust first reported a position in TAK in Q4 2023 and has held it in 10 quarters since. 360 funds tracked by Wall St. Rank hold TAK as of Q1 2026.

Parkside Financial Bank & Trust held 2,560 shares of Takeda Pharmaceutical worth $47.4K as of Q1 2026.
Parkside Financial Bank & Trust left its Takeda Pharmaceutical share count unchanged in Q1 2026.
Takeda Pharmaceutical made up ﹤0.01% of Parkside Financial Bank & Trust's portfolio in Q1 2026, its #975 holding.
Parkside Financial Bank & Trust first reported a position in Takeda Pharmaceutical in Q4 2023 and has held it in 10 quarters since.
360 funds tracked by Wall St. Rank held Takeda Pharmaceutical as of Q1 2026.

Based on Parkside Financial Bank & Trust's 13F filing for Q1 2026, filed 13 May 2026.